devdiscourse23h
FDA's Game-Changing Approvals and Global Health Alerts
The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...
Novo Nordisk Insulin Plans Spark Angst Among Diabetes Patients
About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...
Novo Nordisk Launches Wegovy Weight-Loss Drug in China
The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...
Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...
The Motley Fool3d
Is Novo Nordisk Stock a Buy Right Now?
Novo Nordisk continues to witness strong growth across its portfolio of diabetes and obesity care medications. The company's tailwinds include expanded indications and new geographic markets.
Novo Nordisk’s Ambitious Share Buyback Initiative
Novo Nordisk (NVO) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...
Novo Nordisk says it is gradually phasing out human insulin pens globally
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Hosted on MSN1d
Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says
LONDON (Reuters) -Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of ...